Answers are grounded in this paper and cite their sources.
Comparative evaluation finds consistent therapeutic performance across alternative anticoagulants in heparin-induced thrombocytopenia, supporting oral agents in routine care.
Effectiveness and safety outcomes were similar among various anticoagulants, and significant factors affecting these outcomes were not identified. These findings support fondaparinux and DOACs as viable alternatives to conventional anticoagulants for treatment of acute HIT in clinical practice.
No takes yet. Share an insight, caveat, or question.
Nilius et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: